Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bingkun Zhao

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
International Journal of Oncology|September 19, 2025
[Expression of Concern] miR‑135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2Kaiyao Hua, Jiali Jin, Junyong Zhao, et al.
Frontiers in Bioengineering and Biotechnology|January 28, 2022
SPRC Suppresses Experimental Periodontitis by Modulating Th17/Treg ImbalanceQian Peng, Bingkun Zhao, Jie Lin, et al.
Oncology Reports|October 2, 2018
MicroRNA‑424 serves an anti‑oncogenic role by targeting cyclin‑dependent kinase 1 in breast cancer cellsDan Xie, Hongming Song, Tianqi Wu, et al.
Oncotarget|November 22, 2017
The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cellsDengfeng Li, Hong Wang, Hongming Song, et al.
Plastic and Reconstructive Surgery|September 16, 2022
Short-Term Administration of HIV Protease Inhibitor Saquinavir Improves Skull Bone Healing with Enhanced OsteoclastogenesisHaixia Liu, Yun Shen, Bingkun Zhao, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
International Journal of Oncology|September 19, 2025
[Expression of Concern] miR‑135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2Kaiyao Hua, Jiali Jin, Junyong Zhao, et al.
Frontiers in Bioengineering and Biotechnology|January 28, 2022
SPRC Suppresses Experimental Periodontitis by Modulating Th17/Treg ImbalanceQian Peng, Bingkun Zhao, Jie Lin, et al.
Oncology Reports|October 2, 2018
MicroRNA‑424 serves an anti‑oncogenic role by targeting cyclin‑dependent kinase 1 in breast cancer cellsDan Xie, Hongming Song, Tianqi Wu, et al.
Oncotarget|November 22, 2017
The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cellsDengfeng Li, Hong Wang, Hongming Song, et al.
Plastic and Reconstructive Surgery|September 16, 2022
Short-Term Administration of HIV Protease Inhibitor Saquinavir Improves Skull Bone Healing with Enhanced OsteoclastogenesisHaixia Liu, Yun Shen, Bingkun Zhao, et al.
Pageof 3